Take charge of your gut health on GLP-1 medications with expert dietary support If youre taking a GLP-1 medication and experiencing side effects like nausea or digestive discomfort, youre not alone
GLP-1 medications (Wegovy, Zepbound) are prescription drugs, and HSA-eligible use is generally permitted when prescribed for a qualifying medical condition such as obesity
Clinical trials show that approximately 2540% of total weight lost on semaglutide comes from lean body mass, which includes muscle, bone, and water
In qualitative interviews, respondents elaborated that their CHB status was not internalized as part of their identity, but that they did feel CHB-related stigma, and were cautious about disclosure
lets find the right solution together
In participants with overweight or obesity, once-daily oral semaglutide 25 mg treatment compared with placebo led to greater improvements in glycemic parameters, including HbA1c, fasting plasma glucose, and fasting serum insulin, as well as CV risk factors such as C-reactive protein and serum triglycerides